Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TOTAL COST OF BREAST CARE IS 47% LOWER WITH INCREASED USE OF MAMMOGRAPHIC SCREENING VERSUS NO SCREENING; WORK-UP, TREATMENT SAVINGS REPORTED AT RSNA

This article was originally published in The Gray Sheet

Executive Summary

The cumulative cost of care for breast cancer patients could be almost halved by broadening mammography programs so that 75% of breast cancers are detected via screening, Elizabeth Glenn, MD, Brooke Army Medical Center, Fort Sam Houston, Texas, maintained Dec. 1 at the Radiological Society of North America annual conference in Chicago.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009278

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel